Kilitch Drugs (India) is currently trading at Rs. 179.75, up by 3.75 points or 2.13% from its previous closing of Rs. 176.00 on the BSE.
The scrip opened at Rs. 179.75 and has touched a high and low of Rs. 179.75 and Rs. 179.75 respectively. So far 18 shares were traded on the counter.
The BSE group ‘T’ stock of face value Rs. 10 has touched a 52 week high of Rs. 276.40 on 04-Jan-2022 and a 52 week low of Rs. 79.40 on 15-Mar-2021.
Last one week high and low of the scrip stood at Rs. 179.75 and Rs. 162.35 respectively. The current market cap of the company is Rs. 283.05 crore.
The promoters holding in the company stood at 68.25%, while Institutions and Non-Institutions held 0.03% and 31.73% respectively.
Kilitch Drugs has purchased a land, admeasuring approximately 15 Acres, at Village Maldev, Taluka: Pen, on Pen- Khopoli Highway to establish a green field pharma complex. Kilitch has been one of the prominent manufacturer for Injectables from more than 30 years.
The time is ripe to get into the league of Biotech products to spur the growth. The company plan to setup 4-6 manufacturing units in different therapeutics categories to cater to the growing demands Nationally and Internationally.
All these manufacturing units will be built in line with the company’s growth potential in Export Market. The project envisaged is futuristic and shall have maximum recognition of the world’s leading regulatory authorities.
Kilitch Drugs is a pharmaceutical company, its services range from manufacturing to marketing a host of formulations in all dosage forms i.e. solid, liquid and parenteral forms
